Xatmep (Silvergate Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Xatmep drug offered from Silvergate Pharmaceuticals, Inc.. This Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Silvergate Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | Methotrexate |
| SUBSTANCE NAME: | METHOTREXATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-05-01 |
| END MARKETING DATE: | 0000-00-00 |
Xatmep HUMAN PRESCRIPTION DRUG Details:
| Item Description | Xatmep from Silvergate Pharmaceuticals, Inc. |
| LABELER NAME: | Silvergate Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5(mg/mL) |
| START MARKETING DATE: | 2017-05-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 52652-2001_0720aa9a-4a0d-49e0-90f6-a35e92ec8128 |
| PRODUCT NDC: | 52652-2001 |
| APPLICATION NUMBER: | NDA208400 |
Other METHOTREXATE Pharmaceutical Manufacturers / Labelers:
